Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00204867 · ClinicalTrials.gov registry record
Virtual Colonoscopy (VC) for Primary Colorectal Screening
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 272
- Enrollment target
NCT00204867: Completed study, sponsored by University of Wisconsin, Madison.
NCT00204867 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 272 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00204867 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 272 participants
- Enrollment target
Study Summary
This study involves a primary VC screening for colorectal polyps. The research hypothesis is that VC screening, including surveillance of sub-cm polyps, is a safe and effective approach.
Primary Outcome
Polyp growth rates are established by comparing polyp volume at the initial and surveillance CTC studies
Interventions
- OTHER CTC surveillance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2004-07 |
| Est. Completion | 2016-06 |
What the finished NCT00204867 record still lists
NCT00204867 is an observational study that tracks outcomes without assigning an intervention. The registered 272 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CTC surveillance is the first listed.
NCT00204867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00204867 about?
NCT00204867 is a clinical study titled "Virtual Colonoscopy (VC) for Primary Colorectal Screening". This study involves a primary VC screening for colorectal polyps. The research hypothesis is that VC screening, including surveillance of sub-cm polyps, is a safe and effective approach.
What is the current status of trial NCT00204867?
This trial is currently completed. The enrollment target is 272 participants. The study started on 2004-07. Estimated completion is 2016-06.
What interventions are being tested in trial NCT00204867?
The interventions under investigation include: CTC surveillance (OTHER).
Who is sponsoring clinical trial NCT00204867?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02468024 · 272 participants · Phase 3
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- NCT05519449 · 272 participants · Phase 1
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- NCT06035939 · 272 participants · NA
SMYLS Multi-site Trial
- NCT06083051 · 272 participants · NA
Differences in Postoperative Symptoms With Four Ureteral Stents
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia